Abstract
Falls are a common health problem for older people, and psychotropic medications have been identified as an important independent fall risk factor. The objective of this paper was to review the literature relating to the effect of psychotropic medications on falls in older people, with a particular focus on evidence supporting minimization of their use to reduce risk of falls. A literature search identified 18 randomized trials meeting the inclusion criteria for the review of effectiveness of psychotropic medication withdrawal studies, including four with falls outcomes. One of these, which targeted reduced psychotropic medication use in the community, reported a 66% reduction in falls, while the other studies demonstrated some success in reducing psychotropic medication use but with mixed effects on falls. Other randomized trials evaluated various approaches to reducing psychotropic medications generally or specific classes of psychotropic medications (e.g. benzodiazepines), but did not report fall-related outcomes. Overall, these studies reported moderate success in reducing psychotropic medication use, and a number reported no or limited worsening of key outcomes such as sleep quality or behavioural difficulties associated with withdrawal of psychotropic medication use. Reduced prescription of psychotropic medications (e.g. seeking non-pharmacological alternatives to their use in place of prescription in the first place or, for those patients for whom these medications are deemed necessary, regular monitoring and efforts to cease use or wean off use over time) needs to be a strong focus in clinical practice for three reasons. Firstly, psychotropic medications are commonly prescribed for older people, both in the community and especially in the residential care setting, and their effectiveness in a number of clinical groups has been questioned. Secondly, there is strong evidence of an association between substantially increased risk of falls and use of a number of psychotropic medications, including benzodiazepines (particularly, the long-acting agents), antidepressants and antipsychotic drugs. Finally, the largest effect of any randomized trial of falls prevention to date was achieved with a single intervention consisting of weaning psychotropic drug users off their medications.
Similar content being viewed by others
References
Lord S, Ward J, Williams P, et al. An epidemiological study of falls in older community-dwelling women: the Randwick falls and fractures study. Aust J Public Health 1993; 17:240–5
Kannus P, Parkkari J, Sievanen H, et al. Epidemiology of hip fractures. Bone 1996 Jan; 18(1 Suppl.): 57S–63S
O’Loughlin JL, Robitaille Y, Boivin JF, et al. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993 Feb 1; 137(3): 342–54
Todd C, Skelton D. What are the main risk factors for falls among older people and what are the most effective interventions to prevent these falls? Copenhagen: World Health Organisation Regional Office for Europe (Health Evidence Network report), 2004
Campbell A, Reinken J, Allan B, et al. Falls in old age: a study of frequency and related clinical factors. Age Ageing 1981; 10(4): 264–70
Cassell E, Clapperton A. Preventing injury in Victorian seniors aged 65 years and older. Melbourne: Monash University Accident Research Centre, Victorian Injury Surveillance Unit (VISU), 2008
Cameron I, Murray G, Gillespie L, et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010 Jan 20; (1): CD005465
Gillespie L, Robertson M, Gillespie W, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009 Apr 15; (2): CD007146
Kreisfeld R, Harrison J. Hospital separations due to injury and poisoning 2005–06. Canberra (ACT): Australian Institute of Health and Welfare (AIHW), 2010
Kannus P, Niemi S, Parkkari J, et al. Epidemiology of adulthood injuries: a quickly changing injury profile in Finland. J Clin Epidemiol 2001; 54: 597–602
Moller J. Projected costs of falls related injury to older persons due to demographic change in Australia. Report to the Commonwealth Department of Health and Ageing, under the National Falls Prevention for Older People Initiative. Canberra (ACT): Department of Communications, Information Technology and the Arts, Commonwealth of Australia, 2003
White SM, Griffiths R. Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 2011 Nov;42(11): 1230–3
Kannus P, Niemi S, Parkkari J, et al. Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 1999; 353(9155): 802–5
Wilson RT, Chase GA, Chrischilles EA, et al. Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators. Am J Public Health 2006 Jul; 96(7): 1210–8
Bentler SE, Liu L, Obrizan M, et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 2009 Nov 15; 170(10): 1290–9
Magaziner J, Hawkes W, Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 2000 Sep; 55(9): M498–507
Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep 2003; 1(2): 78–85
Scheffer AC, Schuurmans MJ, van Dijk N, et al. Fear of falling: measurement strategy, prevalence, risk factors and consequences among older persons. Age Ageing 2008 Jan; 37(1): 19–24
Murphy SL, Williams CS, Gill TM. Characteristics associated with fear of falling and activity restriction in community-living older persons. J Am Geriatr Soc 2002 Mar; 50(3): 516–20
Lord S, Sherrington C, Menz H, et al. Falls in older people: risk factors and strategies for prevention. 2nd ed. Cambridge: Cambridge University Press, 2007
Bloch F, Thibaud M, Dugué B, et al. Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis. J Aging Health 2011; 23(2): 329–46
Preville M, Hebert R, Boyer R, et al. Correlates of psychotropic drug use in the elderly compared to adults aged 18–64: results from the Quebec Health Survey. Aging Ment Health 2001 Aug; 5(3): 216–24
Mann E, Kopke S, Haastert B, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr 2009 May 21; 9: 18
Gobert M, D’Hoore W. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatry 2005 Aug; 20(8): 712–21
Hilmer S, Mager D, Simonsick E, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167(8): 781–7
Psychotropic Expert Group. Therapeutic guidelines: psychotropic. Version 6. Melbourne (VIC): Therapeutic Guidelines Limited, 2008
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision (DSMIV-TR). Arlington (VA): American Psychiatric Association, 2000
Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch Intern Med 2009 Dec 14; 169(22): 2128–39
Jorm AF, Grayson D, Creasey H, et al. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 2000 Feb; 24(1): 7–10
Voyer P, Preville M, Cohen D, et al. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can 2010; 29(2): 205–13
Conn DK, Madan R. Use of sleep-promoting medications in nursing home residents: risks versus benefits. Drugs Aging 2006; 23(4): 271–87
Petrovic M, Mariman A, Warie H, et al. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg 2003 Jan–Feb; 58(1): 27–36
Boyle N, Naganathan V, Cumming RG. Medication and falls: risk and optimization. Clin Geriatr Med 2010 Nov; 26(4): 583–605
Johnsen E, Jørgensen HA. Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry 2008; 8: 31
Tandon R. Safety and tolerability: how do newer generation “atypical” antipsychotics compare? Psychiatr Q 2002; 73(4): 297–311
Landi F, Onder G, Cesari M, et al. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005 May; 60(5): 622–6
Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 1998; 44(4): 217–21
Woolcott JC, Richardson KJ, Wiens MO, et al. Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009 Nov 23; 169(21): 1952–60
Deandrea S, Lucenteforte E, Bravi F, et al. Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology 2010; 21(5): 658–68
Vestergaard P. Skeletal effects of central nervous system active drugs: anxiolytics, sedatives, antidepressants, lithium and neuroleptics. Cur Drug Saf 2008; 3(3): 185–9
Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007 Jan 22; 167(2): 188–94
Cumming R, Le Couteur D. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17(11): 825–37
van der Hooft C, Schoofs M, Ziere G, et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 2008; 66(2): 276–82
Ginzburg R, Rosero E. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants. Ann Pharmacother 2009; 43(1): 98–103
Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging 2008; 25(6): 501–19
Wang P, Bohn R, Glynn R, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158(6): 892–8
Wu Q, Liu J, Gallegos-Orozco J, et al. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int 2010; 21(10): 1627–35
Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25(1): 61–70
Panneman MJ, Goettsch WG, Kramarz P, et al. The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study. Drugs Aging 2003; 20(11): 833–9
Kerse N, Flicker L, Pfaff JJ, et al. Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS One 2008; 3(6): e2423
Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 2007 Jun 25; 167(12): 1240–5
Rossi S, editor. Australian medicines handbook 2011. 11th ed. Adelaide (SA): Australian Medicines Handbook Pty. Limited, 2011
Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002 Oct; 50(10): 1629–37
Petty SJ, Hill KD, Haber NE, et al. Balance impairment in chronic antiepileptic drug users: a twin and sibling study. Epilepsia 2009; 51(2): 280–8
Leipzig R, Cumming R, Tinetti M. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30–9
Berdot S, Bertrand M, Dartigues JF, et al. Inappropriate medication use and risk of falls: a prospective study in a large community-dwelling elderly cohort. BMC Geriatr 2009 Jul 23; 9: 30
Lord SR, Anstey KJ, Williams P, et al. Psychoactive medication use, sensori-motor function and falls in older women. Br J Clin Pharmacol 1995 Mar; 39(3): 227–34
Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 2000 Jun; 48(6): 682–5
Golden AG, Ma Q, Nair V, et al. Risk for fractures with centrally acting muscle relaxants: an analysis of a national Medicare Advantage claims database. Ann Pharmacother 2010; 44(9): 1369–75
Passaro A, Volpato S, Romagnoni F, et al. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell’Anziano. J Clin Epidemiol 2000 Dec; 53(12): 1222–9
Ray WA, Thapa PB, Gideon P. Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol Drug Saf 2002 Dec; 11(8): 663–9
Horikawa E, Matsui T, Arai H, et al. Risk of falls in Alzheimer’s disease: a prospective study. Intern Med 2005 Jul; 44(7): 717–21
Chung KA, Lobb BM, Nutt JG, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010; 75(14): 1263–9
Mehta S, Chen H, Johnson ML, et al. Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. Drugs 2010; 27(10): 815–29
Kallin K, Gustafson Y, Sandman PO, et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res 2004 Aug; 16(4): 270–6
Ballard C, Cream J. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument. Int Psychogeriatr 2005 Mar; 17(1): 4–12; discussion 22-9
Campbell A, Robertson M, Gardner M, et al. Psychotropic medication withdrawal and a home based exercise program to prevent falls: a randomised controlled trial. J Am Geriatr Soc 1999; 47(7): 850–3
Patterson S, Hughes C, Crealey G, et al. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland Study). J Am Geriatr Soc 2010; 58: 44–53
Weber V, White A, McIlvried R. An electronic medical record (EMR)-based intervention to reduce polypharmacy and falls in an ambulatory rural elderly population. J Gen Intern Med 2008 Apr; 23(4): 399–404
Pit SW, Byles JE, Henry DA, et al. A Quality Use of Medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust 2007 Jul 2; 187(1): 23–30
Midlöv P, Bondesson A, Eriksson T, et al. Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden. Fam Pract 2006; 23(1): 60–4
Findlay D, Sharma J, McEwen J, et al. Double-blind controlled withdrawal of thioridazine treatment in elderly female inpatients with senile dementia. Int J Geriatr Psychiatry 1989; 4: 115–20
Cohen-Mansfield J, Lipson S, Werner P, et al. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Arch Intern Med 1999; 159(15): 1733–40
Ruths S, Straand J, Nygaard H, et al. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study. J Am Geriatr Soc 2004; 52(10): 1737–43
van Reekum R, Clarke D, Conn D, et al. A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. Int Psychogeriatr 2002; 14(2): 197–210
Ten Wolde G, Dijkstra A, van Empelen P, et al. Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial. Addiction 2008; 103(4): 662–70
Habraken H, Soenen K, Blondeel L, et al. Gradual withdrawal from benzodiazepines in residents of homes for the elderly: experience and suggestions for future research. Eur J Clin Pharmacol 1997; 51(5): 355–8
van Eijk M, Avorn J, Porsius A, et al. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 2001; 322(7287): 654–7
Ulfvarson J, Adami J, Wredling R, et al. Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression. Eur J Clin Pharmacol 2003; 59(10): 735–40
Minett T, Thomas A, Wilkinson L, et al. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 2003; 18(11): 988–93
Ballard C, Hanney ML, Theodoulou M, et al. The Dementia Antipsychotic Withdrawal Trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009 Feb; 8(2): 151–7
Rikala M, Korhonen M, Sulkava R, et al. The effects of medication assessment on psychotropic drug use in the community-dwelling elderly. Int Psychogeriatr 2011; 23(3): 473–84
Hill A, Hoffmann T, Hill K, et al. Measuring falls events in acute hospitals-a comparison of three reporting methods to identify missing data in the hospital reporting system. J Am Geriatr Soc 2010; 58(7): 1347–52
Lamb S, Jørstad-Stein E, Hauer K, et al., Prevention of Falls Network Europe and Outcomes Consensus Group. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 2005; 53(9): 1618–22
Meredith S, Feldman P, Frey D, et al. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc 2002; 50(9): 1484–91
Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006 Nov; 35(6): 586–91
Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004; 2(4): 257–64
Nishtala P, McLachlan A, Bell J, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16(8): 621–32
Oude Voshaar R, Gorgels W, Mol A, et al. Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. Br J Psychiatry 2003; 182: 498–504
Salzman C, Nobel K, Fisher J, et al. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992; 7(7): 89–93
Curran H, Collins R, Fletcher S, et al. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 2003; 33(7): 1223–37
Lindsey PL. Psychotropic medication use among older adults: what all nurses need to know. J Gerontol Nurs 2009 Sep; 35(9): 28–38
Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian community care. Canberra (ACT): ACSQHC, Commonwealth of Australia, 2009
Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian residential aged care facilities. Canberra (ACT): Australian ACSQHC, Commonwealth of Australia, 2009
Australian Commission on Safety and Quality in Healthcare (ACSQHC). Preventing falls and harm from falls in older people: best practice guidelines for Australian hospitals. Canberra (ACT): ACSQHC, Commonwealth of Australia, 2009
National Collaborating Centre for Nursing and Supportive Care. Clinical practice guideline for the assessment and prevention of falls in older people: guidelines commissioned by the National Institute for Clinical Excellence (NICE) [clinical guideline 21]. London: Royal College of Nursing, 2004
Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011 Jan; 59(1): 148–57
Ballard C, Gauthier S, Cummings J, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009; 5(5): 245–55
Hendriks G, Oude Voshaar R, Keijsers G, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 2008; 117(6): 403–11
Oude Voshaar R, Couvée J, van Balkom A, et al. Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry 2006; 189: 213–20
National Ageing Research Institute and Melbourne Extended Care and Rehabilitation Service. Falls risk for older people–community setting (FROP-Com). Parkville (VIC): National Ageing Research Institute (NARI) [online]. Available from URL: http://www.mednwh.unimelb.edu.au/research/pdf_docs/FropCom2009/Falls-risk-for-older-people-community-setting-09.pdf [Accessed 2011 Oct 31]
Russell MA, Hill KD, Blackberry I, et al. The reliability and predictive accuracy of the falls risk for older people in the community assessment (FROP-Com) tool. Age Ageing 2008 Nov; 37(6): 634–9
Fallscreen: the falls risk calculator. Randwick (NSW): Neuroscience Research Australia [online]. Available from URL: http://www.neura.edu.au/index.php?q=FBRG/#The-physiological-assessments [Accessed 2011 Oct 31]
Lord SR, Menz HB, Tiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003 Mar; 83(3): 237–52
Dollman WB, Leblanc VT, Stevens L, et al. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther 2005 Oct; 30(5): 425–32
Dahl LJ, Wright R, Xiao A, et al. Quality improvement in long term care: the psychotropic assessment tool (PAT). J Am Med Dir Assoc 2008 Nov; 9(9): 676–83
Lampe L. Antidepressants: not just for depression. Aust Prescr 2005; 28(4): 91–3
Forsman AK, Schierenbeck I, Wahlbeck K. Psychosocial interventions for the prevention of depression in older adults: systematic review and meta-analysis. J Aging Health 2011; 23(3): 387–416
Krogh J, Nordentoft M, Sterne JA, et al. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 2011; 72(4): 529–38
Windle G, Hughes D, Linck P, et al. Is exercise effective in promoting mental well-being in older age? A systematic review. Aging Ment Health 2010 Aug; 14(6): 652–69
Smith AJ, Tett SE. An intervention to improve benzodiazepine use: anew approach. Fam Pract 2010 Jun; 27(3): 320–7
Smith AJ, Tett SE. Interventions to improve benzodiazepine prescribing, lessons from the past 20 years to guide future interventions. BMC Health Serv Res 2010; 10(1): 321
Cook JM, Marshall R, Masci C, et al. Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 2007 Mar; 22(3): 303–7
Acknowledgements
The authors have no conflicts to declare and have not received any funding for writing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hill, K.D., Wee, R. Psychotropic Drug-Induced Falls in Older People. Drugs Aging 29, 15–30 (2012). https://doi.org/10.2165/11598420-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11598420-000000000-00000